
Histological Progression of Interstitial Fibrosis/Tubular Atrophy (IF/TA) According to Epithelial-Mesenchymal Transition (EMT) Profile: The CERTITEM Trial
Author(s) -
Lionel Rostaing,
Alexandre Hertig,
L. Albano,
Dany Anglicheau,
Antoine Dürrbach,
Olivier Toupance,
B. Moulin,
Pierre Merville,
Marc Hazzan,
Peter Lang,
Guy Touchard,
Bruno Hurault de Ligny,
Stéphane Quéré,
F. Di Giambattista,
Yaëlle Dubois,
Éric Rondeau
Publication year - 2012
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/00007890-201211271-00001
Subject(s) - everolimus , medicine , urology , epithelial–mesenchymal transition , calcineurin , clinical endpoint , regimen , biopsy , gastroenterology , pathology , randomized controlled trial , oncology , transplantation , cancer , metastasis